Grifols S.A. (GRF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.020x

Based on the latest financial reports, Grifols S.A. (GRF) has a cash flow conversion efficiency ratio of 0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€155.27 Million ≈ $181.52 Million USD) by net assets (€7.60 Billion ≈ $8.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Grifols S.A. fund operations to measure how many days the company can operate on defensive assets alone.

Grifols S.A. - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Grifols S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Grifols S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Grifols S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHG:600332	0.044x
Shandong Intco Medical Products Co Ltd SHE:300677	0.024x
Cencosud Shopping SA SN:CENCOMALLS	0.020x
Air Canada TO:AC	0.661x
AAR Corp NYSE:AIR	0.045x
Henan Zhongfu Industrial Co Ltd SHG:600595	0.001x
Hangzhou Cable SHG:603618	-0.069x
Grifols S.A F:G0FB	0.057x

Annual Cash Flow Conversion Efficiency for Grifols S.A. (2005–2024)

The table below shows the annual cash flow conversion efficiency of Grifols S.A. from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Grifols S.A. worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€8.61 Billion ≈ $10.06 Billion	€902.17 Million ≈ $1.05 Billion	0.105x	+301.21%
2023-12-31	€7.97 Billion ≈ $9.32 Billion	€208.28 Million ≈ $243.50 Million	0.026x	+2133.27%
2022-12-31	€8.46 Billion ≈ $9.89 Billion	€-10.87 Million ≈ $-12.70 Million	-0.001x	-101.75%
2021-12-31	€8.15 Billion ≈ $9.52 Billion	€596.98 Million ≈ $697.93 Million	0.073x	-55.65%
2020-12-31	€6.72 Billion ≈ $7.86 Billion	€1.11 Billion ≈ $1.30 Billion	0.165x	+98.81%
2019-12-31	€6.85 Billion ≈ $8.00 Billion	€568.93 Million ≈ $665.14 Million	0.083x	-47.07%
2018-12-31	€4.70 Billion ≈ $5.49 Billion	€737.43 Million ≈ $862.13 Million	0.157x	-32.21%
2017-12-31	€3.63 Billion ≈ $4.25 Billion	€841.75 Million ≈ $984.09 Million	0.232x	+56.07%
2016-12-31	€3.73 Billion ≈ $4.36 Billion	€553.28 Million ≈ $646.84 Million	0.148x	-34.04%
2015-12-31	€3.30 Billion ≈ $3.86 Billion	€742.78 Million ≈ $868.39 Million	0.225x	-38.80%
2014-12-31	€2.66 Billion ≈ $3.11 Billion	€978.93 Million ≈ $1.14 Billion	0.368x	+30.85%
2013-12-31	€2.11 Billion ≈ $2.46 Billion	€592.01 Million ≈ $692.12 Million	0.281x	+4.19%
2012-12-31	€1.88 Billion ≈ $2.20 Billion	€507.12 Million ≈ $592.87 Million	0.270x	+103.85%
2011-12-31	€1.66 Billion ≈ $1.95 Billion	€220.23 Million ≈ $257.47 Million	0.132x	-10.25%
2010-12-31	€707.39 Million ≈ $827.01 Million	€104.25 Million ≈ $121.88 Million	0.147x	-3.31%
2009-12-31	€578.53 Million ≈ $676.36 Million	€88.18 Million ≈ $103.09 Million	0.152x	-0.07%
2008-12-31	€481.28 Million ≈ $562.67 Million	€73.41 Million ≈ $85.82 Million	0.153x	-33.90%
2007-12-31	€384.17 Million ≈ $449.13 Million	€88.64 Million ≈ $103.63 Million	0.231x	+73.19%
2006-12-31	€368.35 Million ≈ $430.64 Million	€49.08 Million ≈ $57.38 Million	0.133x	-93.77%
2005-12-31	€55.95 Million ≈ $65.41 Million	€119.72 Million ≈ $139.97 Million	2.140x	--

About Grifols S.A.

MC:GRF Spain Drug Manufacturers - General

Market Cap

$4.43 Billion

€3.79 Billion EUR

Market Cap Rank

#3888 Global

#31 in Spain

Share Price

€8.97

Change (1 day)

-1.43%

52-Week Range

€8.67 - €13.52

All Time High

€33.56